Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis

American Journal of Psychiatry

Volumn 164, Issue 7, 2007, Pages 1105-1114

  Matsuzawa, Daisuke ^b   Hashimoto, Kenji ^a   Miyatake, Ryosuke ^b   Shirayama, Yukihiko ^b   Shimizu, Eiji ^b   Maeda, Kazuhisa ^b   Suzuki, Yoichi ^b   Mashimo, Yoichi ^b   Sekine, Yoshimoto ^b   Inada, Toshiya ^b   Ozaki, Norio ^b   Iwata, Nakao ^b   Harano, Mutsuo ^b   Komiyama, Tokutaro ^b   Yamada, Mitsuhiko ^b   Sora, Ichiro ^b   Ujike, Hiroshi ^b   Hata, Akira ^b   Sawa, Akira ^b   Iyo, Masaomi ^b  

^a CHIBA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; METHAMPHETAMINE; PROTEIN INTERACTING WITH PROTEIN KINASE C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC TRANSCRIPTION; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 34547219839     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.7.1105     Document Type: Article

References (35)

1. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, Zhang H, O'Malley SS, Rounsaville BJ: Familial transmission of substance use disorders. Arch Gen Psychiatry 1998; 55:973-979
2. Kosten TR, Markou A, Koob GF: Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis 1998; 186:737-745
3. Kendler KS, Karkowski LM, Neale MC, Prescott CA: Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 2000; 57:261-269
4. Uhl GR, Liu QR, Naiman D: Substance abuse vulnerability loci: converging genome scanning data. Trends Genet 2002; 18:420-425
5. Goldman D, Oroszi G, Ducci F: The genetics of addictions: uncovering the genes. Nat Rev Genet 2005; 6:521-532
6. Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG: Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci 1998; 18:4861-4869
7. Frey K, Kilbourn M, Robinson T: Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur J Pharmacol 1997; 334:273-279
8. Blakely RD, Bauman AL: Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol 2000; 10:28-36
9. Robinson MB: Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J Neurochem 2002; 80:1-11
10. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN: Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001; 158:377-382
11. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N: Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 2001; 158:1206-1214
12. Ujike H, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y, Sora I, Iyo M, Katsu T, Nomura A, Nakata K, Ozaki N: Nine-or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J 2003; 3:242-247
13. Staudinger J, Zhou J, Burgess R, Elledge SJ, Olson EN: PICK1: a perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system. J Cell Biol 1995; 128:263-271
14. Xia J, Zhang X, Staudinger J, Huganir RL: Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. Neuron 1999; 22:179-187
15. Deken SL, Beckman ML, Quick MW: Picking on transporters. Trends Neurosci 2001; 24:623-625
16. Torres GE, Yao WD, Mohn AR, Quan H, Kim KM, Levey AI, Staudinger J, Caron MG: Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 2001; 30:121-134
17. Stober G, Meyer J, Nanda I, Wienker TF, Saar K, Knapp M, Jatzke S, Schmid M, Lesch KP, Beckmann H: Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q13. Am J Med Genet 2000; 96:392-397
18. Snyder SH: Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry 1972; 27:169-179
19. Hong CJ, Liao DL, Shih HL, Tsai SJ: Association study of PICK1 rs3952 polymorphism and schizophrenia. Neuroreport 2004; 15:1965-1967
20. Fujii K, Maeda K, Hikida T, Mustafa AK, Balkissoon R, Xia J, Yamada T, Ozeki Y, Kawahara R, Okawa M, Huganir RL, Ujike H, Snyder SH, Sawa A: Serine racemase binds to PIC1: potential relevance to schizophrenia. Mol Psychiatry 2006; 11:150-157
21. Sato M, Chen CC, Akiyama K, Otsuki S: Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 1983; 18:429-440
22. Sato M, Numachi Y, Hamamura T: Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 1992; 18:115-122
23. Hanley JG, Henley JM: PICK1 is a calcium-sensor for NMDA-induced AMPA receptor trafficking. EMBO J 2005; 24:3266-3278
24. Dev KK, Nakajima Y, Kitano J, Braithwaite SP, Henley JM, Nakanishi S: PICK1 interacts with and regulates PKC phosphorylation of mGLUR7. J Neurosci 2000; 20:7252-7257
25. Perroy J, El Far O, Bertaso F, Pin JP, Betz H, Bockaert J, Fagni L: PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7. EMBO J 2002; 21:2990-2999
26. Bellone C, Luscher C: Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGLUR-dependent long-term depression. Nat Neurosci 2006; 9:636-641
27. Kenny PJ, Markou A: The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol Sci 2004; 25:265-272
28. Sutton MA, Schmidt EF, Choi KH, Schad CA, Whisler K, Simmons D, Karanian DA, Monteggia LM, Neve RL, Self DW: Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature 2003; 421:70-75
29. Javitt DC: Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry 2004; 9:984-997
30. Wolosker H, Blackshaw S, Snyder SH: Serine racemase: a glial enzyme synthesizing D-serineto regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci USA 1999; 96:13409-13414
31. Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri C, Okada S, Hasegawa H, Imai K, Iyo M: Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 2003; 60:572-576
32. Hashimoto K, Shimizu E, Iyo M: Dysfunction of glia-neuron communication in pathophysiology of schizophrenia. Curr Psychiatry Rev 2005; 1:151-163
33. Yamada K, Ohnishi T, Hashimoto K, Ohba H, Iwayama-Shigeno Y, Toyoshima M, Okuno A, Takao H, Toyota T, Minabe Y, Nakamura K, Shimizu E, Itokawa M, Mori N, Iyo M, Yoshikawa T: Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels. Biol Psychiatry 2005; 57:1493-1503
34. Boehning D, Snyder SH: Novel neural modulators. Annu Rev Neurosci 2003; 26:105-131
35. Mustafa AK, Kim PM, Snyder SH: D-serine as a putative glial neurotransmitter. Neuron Glia Biol 2004; 1:275-281